Sino Agro Food, Inc. Changes Auditor
Sino Agro Food, Inc. Changes Auditor ECOVIS HK Resigns to Concentrate on Hong Kong Companies, Dropping All U.S. Public Companies |
| [29-June-2018] |
STOCKHOLM, June 29, 2018 /PRNewswire/ -- Sino Agro Food, Inc. (OTCQX: SIAF) (OSE: SIAF-ME) (the "Company"), is an integrated, diversified agriculture technology and organic food company with principal operations as a primary producer, processor and marketer of protein foods in the People's Republic of China. ECOVIS David Yeung Hong Kong ("ECOVIS HK") has informed the Company that his firm must resign as the Company's independent registered public accounting firm due to its decision to discontinue handling auditing services for US public companies, mainly arising from its limited resources to serve the growing demand it is receiving from existing and new HK public registered company clients. The Company understands the situation and expresses its appreciation to ECOVIS HK for its dedicated service over the past three years. As a result of ECOVIS HK's resignation, on June 29, 2018, the Company appointed ZHEN HUI CPA ("ZHCPA") as its new independent registered public accounting firm. ZHCPA provides a range of auditing services conducted under U.S. GAAP, IFRS, and Chinese accounting standards. ZHCPA is registered with the Public Company Accounting Oversight Board (PCAOB), the Hong Kong Institute of Certified Public Accountants (HKICPA), and the Chartered Accountants in England and Wales (ICAEW). Further information regarding ZHCPA can be accessed via the web at http://zhenhuicpa.com This information was brought to you by Cision http://news.cision.com http://news.cision.com/sino-agro-food/r/sino-agro-food--inc--changes-auditor,c2561690 The following files are available for download: CONTACT: Peter Grossman Todd Fromer / Elizabeth Barker Nordic Countries
SOURCE Sino Agro Food | ||
Company Codes: ISIN:US8293552050, Oslo:SIAF-ME, OTC-PINK:SIAF, Stuttgart:S4F, OTC-QX:SIAF, OtherOTC:SIAF |
View original content:© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}Sanofi: First patient outside U.S. treated in global Kevzara (sarilumab) clinical trial program for patients with severe COVID-19
